VOYA Investment Management
OVID icon

VOYA Investment Management’s Ovid Therapeutics OVID Stock Holding History

VOYA Investment Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.8K Buy
+29,278
New +$75.5K ﹤0.01% 2387
2024
Q2 		– Sell
-22,819
Closed -$69.6K – 2888
2024
Q1 		$69.6K Sell
22,819
-3,978
-15% -$13.3K ﹤0.01% 2686
2023
Q4 		$86.3K Buy
26,797
+972
+4% +$3.32K ﹤0.01% 2788
2023
Q3 		$99.2K Hold
25,825
– – ﹤0.01% 2738
2023
Q2 		$84.7K Buy
+25,825
New +$87.7K ﹤0.01% 2833
2021
Q2 		– Sell
-23,641
Closed -$95K – 2876
2021
Q1 		$95K Buy
23,641
+3,559
+18% +$11.8K ﹤0.01% 2677
2020
Q4 		$46K Buy
20,082
+5,233
+35% +$24.4K ﹤0.01% 2662
2020
Q3 		$85K Hold
14,849
– – ﹤0.01% 2370
2020
Q2 		$109K Buy
+14,849
New +$69.5K ﹤0.01% 2319

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

VOYA Investment Management's OVID Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 29,278 shares worth $78.8K. The stake represents ﹤0.01% of the portfolio and ranks #2387 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in OVID as recently as Q1 2024.

VOYA Investment Management first reported a position in OVID in Q2 2020 and has held it in 9 quarters since. The position peaked at $109K in Q2 2020. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • VOYA Investment Management held 29,278 shares of Ovid Therapeutics worth $78.8K as of Q2 2026.
  • Ovid Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2387 holding.
  • VOYA Investment Management first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 9 quarters since.
  • VOYA Investment Management's Ovid Therapeutics position peaked at $109K in Q2 2020.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.